His primary areas of investigation include Breast cancer, Internal medicine, Cancer, Oncology and Genetics. D. Gareth Evans combines subjects such as Cancer research, Genetic predisposition, Gynecology and Single-nucleotide polymorphism, Genotype with his study of Breast cancer. His work is dedicated to discovering how Cancer, Genetic counseling are connected with Family history and other disciplines.
His Oncology study also includes fields such as
The scientist’s investigation covers issues in Breast cancer, Internal medicine, Oncology, Cancer and Genetics. His Breast cancer study integrates concerns from other disciplines, such as Prospective cohort study, Gynecology, Family history and Family medicine. His biological study deals with issues like Germline mutation, which deal with fields such as Germline.
His work in Oncology addresses issues such as Cohort, which are connected to fields such as Cohort study. His Cancer research includes themes of Cancer research and Risk factor. Mutation, Allele, Single-nucleotide polymorphism, Genotype and Genome-wide association study are among the areas of Genetics where D. Gareth Evans concentrates his study.
D. Gareth Evans mainly focuses on Internal medicine, Breast cancer, Oncology, Cancer and Family medicine. In his study, which falls under the umbrella issue of Internal medicine, Medical genetics, Li–Fraumeni syndrome, Bioinformatics and Germline mutation is strongly linked to Germline. His studies deal with areas such as Proportional hazards model, Cohort study and Obstetrics as well as Breast cancer.
His studies examine the connections between Oncology and genetics, as well as such issues in PALB2, with regards to CHEK2. His Cancer study frequently links to other fields, such as Gene. D. Gareth Evans has researched Family medicine in several fields, including Underserved Population and Breast screening.
D. Gareth Evans focuses on Internal medicine, Breast cancer, Oncology, Lynch syndrome and Family medicine. D. Gareth Evans frequently studies issues relating to Germline and Internal medicine. The various areas that D. Gareth Evans examines in his Breast cancer study include Odds ratio, Cohort study and Hazard ratio.
His Oncology research is multidisciplinary, incorporating perspectives in Single-nucleotide polymorphism, Genetic association, Cohort and PALB2. His Lynch syndrome research focuses on Endometrial cancer and how it connects with MLH1, MSH2, Colorectal cancer, MSH6 and Genetic counseling. His research integrates issues of Young adult, Phenotype, Malignancy and Genomics in his study of Cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
A. Antoniou;P.D.P. Pharoah;S. Narod;H.A. Risch.
American Journal of Human Genetics (2003)
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah.
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips.
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek;Tara M. Friebel;Christian F. Singer;D. Gareth Evans.
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
Timothy R. Rebbeck;Tara Friebel;Henry T. Lynch;Susan L. Neuhausen.
Journal of Clinical Oncology (2004)
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations
Hanne Meijers-Heijboer;Ans van den Ouweland;Jan Klijn;Marijke Wasielewski.
Nature Genetics (2002)
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M O Leach;C R M Boggis;A K Dixon;D F Easton.
The Lancet (2005)
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
D G R Evans;M E Baser;J McGaughran;S Sharif.
Journal of Medical Genetics (2002)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman;Sheila Seal;Deborah Thompson;Patrick Kelly.
Nature Genetics (2007)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn;Anne Marie Gerdes;Finlay MacRae;Jukka Pekka Mecklin.
The Lancet (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: